Filing Flows › Integra Lifesciences Holdings (IART) › Tissue Reconstruction revenue
Integra Lifesciences Holdings (IART) Tissue Reconstruction revenue by quarter
Integra Lifesciences Holdings' Tissue Reconstruction revenue was $107M in Q3 2026 (third quarter 2026), -2% from Q2 2026. Over the last 3 quarters it ranged from $107M (Q3 2026) to $109M (Q2 2026).
| Quarter | Tissue Reconstruction revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $107M | -2% | — |
| Q2 2026 | $109M | +0.7% | — |
| Q1 2026 | $109M | — | — |
Q3 2026 at a glance
Integra Lifesciences Holdings, Q3 2026: revenue $411M (+2% year over year), operating margin 4.6%, net earnings $14.9M, operating cash flow $96.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Integra Lifesciences Holdings' Tissue Reconstruction revenue?
Integra Lifesciences Holdings' Tissue Reconstruction revenue was $107M in Q3 2026 (third quarter 2026), -2% from Q2 2026.
How has Integra Lifesciences Holdings' Tissue Reconstruction revenue changed?
Over the last 3 quarters it ranged from $107M (Q3 2026) to $109M (Q2 2026).
Q3 2026 results → · How Integra Lifesciences Holdings makes money →